These findings now await translation into large animal models and clinical research in human AKI, with the aid of dynamic monitoring of kidney S100A8/A9+ macrophage infiltration through urine S100A8/A9 detection, for precisely treating human AKI. This evidence concerns the gene IGKV1D-22 and acute kidney injury.